
### [NCIT:C3520](http://purl.obolibrary.org/obo/NCIT_C3520)
**Label:** Myeloid Sarcoma

**Subclasses:** [NCIT:C35816](http://purl.obolibrary.org/obo/NCIT_C35816) (Monoblastic Sarcoma), [NCIT:C35815](http://purl.obolibrary.org/obo/NCIT_C35815) (Granulocytic Sarcoma), [NCIT:C5527](http://purl.obolibrary.org/obo/NCIT_C5527) (Prostate Myeloid Sarcoma), [NCIT:C7008](http://purl.obolibrary.org/obo/NCIT_C7008) (Intracranial Myeloid Sarcoma), [NCIT:C45741](http://purl.obolibrary.org/obo/NCIT_C45741) (Mediastinal Myeloid Sarcoma), [NCIT:C5370](http://purl.obolibrary.org/obo/NCIT_C5370) (Cardiac Myeloid Sarcoma), 

**Class expressions from DL-Learner:**

- [NCIT:C43229](http://purl.obolibrary.org/obo/NCIT_C43229) (Primitive Bone Marrow Myeloid Stem Cell) 66.67%
- Thing 51.13%
- [CL:0000049](http://purl.obolibrary.org/obo/CL_0000049) (common myeloid progenitor) 33.33%
- [CL:0002032](http://purl.obolibrary.org/obo/CL_0002032) (hematopoietic oligopotent progenitor cell) 29.58%
- [CL:0008001](http://purl.obolibrary.org/obo/CL_0008001) (hematopoietic precursor cell) 25.51%
- [CL:0000988](http://purl.obolibrary.org/obo/CL_0000988) (hematopoietic cell) 21.57%
- [CL:0002371](http://purl.obolibrary.org/obo/CL_0002371) (somatic cell) 19.72%
- [CL:0000255](http://purl.obolibrary.org/obo/CL_0000255) (eukaryotic cell) 19.64%
- [CL:0000003](http://purl.obolibrary.org/obo/CL_0000003) (native cell) 19.43%
- [GO:0005623](http://purl.obolibrary.org/obo/GO_0005623) (cell) 19.42%
- [CL:0000000](http://purl.obolibrary.org/obo/CL_0000000) (cell) 19.39%
- [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) 19.23%
- [NCIT:C12913](http://purl.obolibrary.org/obo/NCIT_C12913) (Abnormal Cell) 19.03%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 18.02%
- [BFO:0000002](http://purl.obolibrary.org/obo/BFO_0000002) (null) 17.69%


